Gene Therapy For Heart Failure Market, Global Outlook and Forecast 2022-2028

January 2022 | 61 pages | ID: GA1349FD372FEN
Market Monitor Global

Abstracts

Shared power bank refers to the charging rental equipment provided by the company. The user can rent a power bank by scanning the QR code on the device screen with a mobile device to pay a deposit. After the power bank is successfully returned, the deposit can be withdrawn and returned to the account at any time.

This report contains market size and forecasts of Shared Power Bank in Global, including the following market information:

Global Shared Power Bank Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Shared Power Bank market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Desktop Sharing Power Bank Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Shared Power Bank include Power Share, Flash Charge, Power Bank Rent, Charge Buddy, ETEK, Spider Charge, WINNSEN INDUSTRY, WATTAH and Power2Impact and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Shared Power Bank companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Shared Power Bank Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Shared Power Bank Market Segment Percentages, by Type, 2021 (%)

• Desktop Sharing Power Bank
• Cabinet-Type Shared Power Bank
• Others

Global Shared Power Bank Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Shared Power Bank Market Segment Percentages, by Application, 2021 (%)

• Restaurant
• Bus Stop
• The Mall
• Others

Global Shared Power Bank Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Shared Power Bank Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Shared Power Bank revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Shared Power Bank revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Power Share
• Flash Charge
• Power Bank Rent
• Charge Buddy
• ETEK
• Spider Charge
• WINNSEN INDUSTRY
• WATTAH
• Power2Impact
• ChargeFon

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Gene Therapy For Heart Failure Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Gene Therapy For Heart Failure Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GENE THERAPY FOR HEART FAILURE OVERALL MARKET SIZE

2.1 Global Gene Therapy For Heart Failure Market Size: 2021 VS 2028
2.2 Global Gene Therapy For Heart Failure Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Gene Therapy For Heart Failure Players in Global Market
3.2 Top Global Gene Therapy For Heart Failure Companies Ranked by Revenue
3.3 Global Gene Therapy For Heart Failure Revenue by Companies
3.4 Top 3 and Top 5 Gene Therapy For Heart Failure Companies in Global Market, by Revenue in 2021
3.5 Global Companies Gene Therapy For Heart Failure Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Therapy For Heart Failure Players in Global Market
  3.6.1 List of Global Tier 1 Gene Therapy For Heart Failure Companies
  3.6.2 List of Global Tier 2 and Tier 3 Gene Therapy For Heart Failure Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Gene Therapy For Heart Failure Market Size Markets, 2021 & 2028
  4.1.2 Gene Modification
  4.1.3 Gene Replacement
  4.1.4 Others
4.2 By Type - Global Gene Therapy For Heart Failure Revenue & Forecasts
  4.2.1 By Type - Global Gene Therapy For Heart Failure Revenue, 2017-2022
  4.2.2 By Type - Global Gene Therapy For Heart Failure Revenue, 2023-2028
  4.2.3 By Type - Global Gene Therapy For Heart Failure Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Gene Therapy For Heart Failure Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Laboratory
  5.1.4 Others
5.2 By Application - Global Gene Therapy For Heart Failure Revenue & Forecasts
  5.2.1 By Application - Global Gene Therapy For Heart Failure Revenue, 2017-2022
  5.2.2 By Application - Global Gene Therapy For Heart Failure Revenue, 2023-2028
  5.2.3 By Application - Global Gene Therapy For Heart Failure Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Gene Therapy For Heart Failure Market Size, 2021 & 2028
6.2 By Region - Global Gene Therapy For Heart Failure Revenue & Forecasts
  6.2.1 By Region - Global Gene Therapy For Heart Failure Revenue, 2017-2022
  6.2.2 By Region - Global Gene Therapy For Heart Failure Revenue, 2023-2028
  6.2.3 By Region - Global Gene Therapy For Heart Failure Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Gene Therapy For Heart Failure Revenue, 2017-2028
  6.3.2 US Gene Therapy For Heart Failure Market Size, 2017-2028
  6.3.3 Canada Gene Therapy For Heart Failure Market Size, 2017-2028
  6.3.4 Mexico Gene Therapy For Heart Failure Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Gene Therapy For Heart Failure Revenue, 2017-2028
  6.4.2 Germany Gene Therapy For Heart Failure Market Size, 2017-2028
  6.4.3 France Gene Therapy For Heart Failure Market Size, 2017-2028
  6.4.4 U.K. Gene Therapy For Heart Failure Market Size, 2017-2028
  6.4.5 Italy Gene Therapy For Heart Failure Market Size, 2017-2028
  6.4.6 Russia Gene Therapy For Heart Failure Market Size, 2017-2028
  6.4.7 Nordic Countries Gene Therapy For Heart Failure Market Size, 2017-2028
  6.4.8 Benelux Gene Therapy For Heart Failure Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Gene Therapy For Heart Failure Revenue, 2017-2028
  6.5.2 China Gene Therapy For Heart Failure Market Size, 2017-2028
  6.5.3 Japan Gene Therapy For Heart Failure Market Size, 2017-2028
  6.5.4 South Korea Gene Therapy For Heart Failure Market Size, 2017-2028
  6.5.5 Southeast Asia Gene Therapy For Heart Failure Market Size, 2017-2028
  6.5.6 India Gene Therapy For Heart Failure Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Gene Therapy For Heart Failure Revenue, 2017-2028
  6.6.2 Brazil Gene Therapy For Heart Failure Market Size, 2017-2028
  6.6.3 Argentina Gene Therapy For Heart Failure Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Gene Therapy For Heart Failure Revenue, 2017-2028
  6.7.2 Turkey Gene Therapy For Heart Failure Market Size, 2017-2028
  6.7.3 Israel Gene Therapy For Heart Failure Market Size, 2017-2028
  6.7.4 Saudi Arabia Gene Therapy For Heart Failure Market Size, 2017-2028
  6.7.5 UAE Gene Therapy For Heart Failure Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Askbio
  7.1.1 Askbio Corporate Summary
  7.1.2 Askbio Business Overview
  7.1.3 Askbio Gene Therapy For Heart Failure Major Product Offerings
  7.1.4 Askbio Gene Therapy For Heart Failure Revenue in Global Market (2017-2022)
  7.1.5 Askbio Key News
7.2 RENOVACORINC
  7.2.1 RENOVACORINC Corporate Summary
  7.2.2 RENOVACORINC Business Overview
  7.2.3 RENOVACORINC Gene Therapy For Heart Failure Major Product Offerings
  7.2.4 RENOVACORINC Gene Therapy For Heart Failure Revenue in Global Market (2017-2022)
  7.2.5 RENOVACORINC Key News
7.3 Uniqure
  7.3.1 Uniqure Corporate Summary
  7.3.2 Uniqure Business Overview
  7.3.3 Uniqure Gene Therapy For Heart Failure Major Product Offerings
  7.3.4 Uniqure Gene Therapy For Heart Failure Revenue in Global Market (2017-2022)
  7.3.5 Uniqure Key News
7.4 DINAQOR
  7.4.1 DINAQOR Corporate Summary
  7.4.2 DINAQOR Business Overview
  7.4.3 DINAQOR Gene Therapy For Heart Failure Major Product Offerings
  7.4.4 DINAQOR Gene Therapy For Heart Failure Revenue in Global Market (2017-2022)
  7.4.5 DINAQOR Key News
7.5 PRECIGEN
  7.5.1 PRECIGEN Corporate Summary
  7.5.2 PRECIGEN Business Overview
  7.5.3 PRECIGEN Gene Therapy For Heart Failure Major Product Offerings
  7.5.4 PRECIGEN Gene Therapy For Heart Failure Revenue in Global Market (2017-2022)
  7.5.5 PRECIGEN Key News
7.6 Heartseed
  7.6.1 Heartseed Corporate Summary
  7.6.2 Heartseed Business Overview
  7.6.3 Heartseed Gene Therapy For Heart Failure Major Product Offerings
  7.6.4 Heartseed Gene Therapy For Heart Failure Revenue in Global Market (2017-2022)
  7.6.5 Heartseed Key News
7.7 Cardior
  7.7.1 Cardior Corporate Summary
  7.7.2 Cardior Business Overview
  7.7.3 Cardior Gene Therapy For Heart Failure Major Product Offerings
  7.7.4 Cardior Gene Therapy For Heart Failure Revenue in Global Market (2017-2022)
  7.7.5 Cardior Key News
7.8 NOVARTIS
  7.8.1 NOVARTIS Corporate Summary
  7.8.2 NOVARTIS Business Overview
  7.8.3 NOVARTIS Gene Therapy For Heart Failure Major Product Offerings
  7.8.4 NOVARTIS Gene Therapy For Heart Failure Revenue in Global Market (2017-2022)
  7.8.5 NOVARTIS Key News
7.9 Blue Rock
  7.9.1 Blue Rock Corporate Summary
  7.9.2 Blue Rock Business Overview
  7.9.3 Blue Rock Gene Therapy For Heart Failure Major Product Offerings
  7.9.4 Blue Rock Gene Therapy For Heart Failure Revenue in Global Market (2017-2022)
  7.9.5 Blue Rock Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Gene Therapy For Heart Failure Market Opportunities & Trends in Global Market
Table 2. Gene Therapy For Heart Failure Market Drivers in Global Market
Table 3. Gene Therapy For Heart Failure Market Restraints in Global Market
Table 4. Key Players of Gene Therapy For Heart Failure in Global Market
Table 5. Top Gene Therapy For Heart Failure Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Gene Therapy For Heart Failure Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Gene Therapy For Heart Failure Revenue Share by Companies, 2017-2022
Table 8. Global Companies Gene Therapy For Heart Failure Product Type
Table 9. List of Global Tier 1 Gene Therapy For Heart Failure Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene Therapy For Heart Failure Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Gene Therapy For Heart Failure Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Gene Therapy For Heart Failure Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Gene Therapy For Heart Failure Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Gene Therapy For Heart Failure Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Gene Therapy For Heart Failure Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Gene Therapy For Heart Failure Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Gene Therapy For Heart Failure Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Gene Therapy For Heart Failure Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Gene Therapy For Heart Failure Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Gene Therapy For Heart Failure Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Gene Therapy For Heart Failure Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Gene Therapy For Heart Failure Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Gene Therapy For Heart Failure Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Gene Therapy For Heart Failure Revenue, (US$, Mn), 2023-2028
Table 30. Askbio Corporate Summary
Table 31. Askbio Gene Therapy For Heart Failure Product Offerings
Table 32. Askbio Gene Therapy For Heart Failure Revenue (US$, Mn), (2017-2022)
Table 33. RENOVACORINC Corporate Summary
Table 34. RENOVACORINC Gene Therapy For Heart Failure Product Offerings
Table 35. RENOVACORINC Gene Therapy For Heart Failure Revenue (US$, Mn), (2017-2022)
Table 36. Uniqure Corporate Summary
Table 37. Uniqure Gene Therapy For Heart Failure Product Offerings
Table 38. Uniqure Gene Therapy For Heart Failure Revenue (US$, Mn), (2017-2022)
Table 39. DINAQOR Corporate Summary
Table 40. DINAQOR Gene Therapy For Heart Failure Product Offerings
Table 41. DINAQOR Gene Therapy For Heart Failure Revenue (US$, Mn), (2017-2022)
Table 42. PRECIGEN Corporate Summary
Table 43. PRECIGEN Gene Therapy For Heart Failure Product Offerings
Table 44. PRECIGEN Gene Therapy For Heart Failure Revenue (US$, Mn), (2017-2022)
Table 45. Heartseed Corporate Summary
Table 46. Heartseed Gene Therapy For Heart Failure Product Offerings
Table 47. Heartseed Gene Therapy For Heart Failure Revenue (US$, Mn), (2017-2022)
Table 48. Cardior Corporate Summary
Table 49. Cardior Gene Therapy For Heart Failure Product Offerings
Table 50. Cardior Gene Therapy For Heart Failure Revenue (US$, Mn), (2017-2022)
Table 51. NOVARTIS Corporate Summary
Table 52. NOVARTIS Gene Therapy For Heart Failure Product Offerings
Table 53. NOVARTIS Gene Therapy For Heart Failure Revenue (US$, Mn), (2017-2022)
Table 54. Blue Rock Corporate Summary
Table 55. Blue Rock Gene Therapy For Heart Failure Product Offerings
Table 56. Blue Rock Gene Therapy For Heart Failure Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Gene Therapy For Heart Failure Segment by Type in 2021
Figure 2. Gene Therapy For Heart Failure Segment by Application in 2021
Figure 3. Global Gene Therapy For Heart Failure Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Gene Therapy For Heart Failure Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gene Therapy For Heart Failure Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gene Therapy For Heart Failure Revenue in 2021
Figure 8. By Type - Global Gene Therapy For Heart Failure Revenue Market Share, 2017-2028
Figure 9. By Application - Global Gene Therapy For Heart Failure Revenue Market Share, 2017-2028
Figure 10. By Region - Global Gene Therapy For Heart Failure Revenue Market Share, 2017-2028
Figure 11. By Country - North America Gene Therapy For Heart Failure Revenue Market Share, 2017-2028
Figure 12. US Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Gene Therapy For Heart Failure Revenue Market Share, 2017-2028
Figure 16. Germany Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2028
Figure 17. France Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Gene Therapy For Heart Failure Revenue Market Share, 2017-2028
Figure 24. China Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2028
Figure 28. India Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Gene Therapy For Heart Failure Revenue Market Share, 2017-2028
Figure 30. Brazil Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Gene Therapy For Heart Failure Revenue Market Share, 2017-2028
Figure 33. Turkey Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Gene Therapy For Heart Failure Revenue, (US$, Mn), 2017-2028
Figure 37. Askbio Gene Therapy For Heart Failure Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. RENOVACORINC Gene Therapy For Heart Failure Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Uniqure Gene Therapy For Heart Failure Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. DINAQOR Gene Therapy For Heart Failure Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. PRECIGEN Gene Therapy For Heart Failure Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Heartseed Gene Therapy For Heart Failure Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Cardior Gene Therapy For Heart Failure Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. NOVARTIS Gene Therapy For Heart Failure Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Blue Rock Gene Therapy For Heart Failure Revenue Year Over Year Growth (US$, Mn) & (2017-2022)